Federal Register of Legislation - Australian Government

Primary content

PB 23 of 2012 Arrangements as made
This instrument revokes the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011) (CPAP) and the National Health (Trastuzumab) Special Arrangement 2011 (No. PB 94 of 2011) (Trastuzumab). CPAP and Trastuzumab are replaced by special arrangement, the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (No. PB 79 of 2011) (EFC) which commenced on 1 December 2011. It was intended that all suppliers (including public hospital authorities) would commence supplying chemotherapy medicines under EFC from 1 December 2011 and that CPAP and Trastuzumab would be revoked on that day, however software delays meant that some public hospitals were unable to transition on that date. From 1 April 2012 chemotherapy medicines will no longer be able to be supplied by public hospitals under CPAP or Trastuzumab, as, on that date, both CPAP and Trastuzumab special arrangements will be revoked by this instrument.
Administered by: Health
Registered 30 Mar 2012
Tabling HistoryDate
Tabled HR08-May-2012
Tabled Senate10-May-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 23 of 2012

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsection 100 (2) of the National Health Act 1953.

Dated                      27         March 2012

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

 

1              Name of Instrument

                (1)    This instrument is the National Health Special Arrangement

                       Revocation Instrument 2012.

 

                (2)    This instrument may also be cited as PB 23 of 2012.

2              Commencement

                This instrument commences on 1 April 2012.

3              Revocation

                The following legislative instruments are revoked:

 

(1) National Health (Chemotherapy Pharmaceuticals Access Program)

     Special Arrangement 2011 (PB 87 of 2011)

 

(2) National Health (Trastuzumab) Special Arrangement 2011 (PB 94 of

     2011)     

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au